{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:11:17Z","timestamp":1774923077524,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1007\/s11940-002-0047-8","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T20:28:42Z","timestamp":1180988922000},"page":"365-373","source":"Crossref","is-referenced-by-count":29,"title":["The use of botulinum toxin type A in headache treatment"],"prefix":"10.1007","volume":"4","author":[{"given":"Ninan T.","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex O.","family":"Kaup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/(SICI)1097-4598(1997)6+<129::AID-MUS9>3.0.CO;2-B","volume":"20","author":"J Jankovic","year":"1997","unstructured":"Jankovic J, Brin MF: Botulinum toxin: historical perspective and potential new indications. Muscle Nerve 1997, 20(suppl):S129-S145.","journal-title":"Muscle Nerve"},{"key":"47_CR2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","volume":"285","author":"SS Arnon","year":"2001","unstructured":"Arnon SS, Schecter R, Inglesby TV, et al.: Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001, 285:1059\u20131070. A good article.","journal-title":"JAMA"},{"key":"47_CR3","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199104253241707","volume":"324","author":"J Jankovic","year":"1991","unstructured":"Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N Eng J Med 1991, 324:1186\u20131194.","journal-title":"N Eng J Med"},{"key":"47_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410280407","volume":"28","author":"BJ Snow","year":"1990","unstructured":"Snow BJ, Tsui JKC, Bhatt MH, et al.: Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990, 28:512\u2013515.","journal-title":"Ann Neurol"},{"key":"47_CR5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0140-6736(93)90109-T","volume":"341","author":"PJ Pasricha","year":"1999","unstructured":"Pasricha PJ, Ravich WJ, Kaloo AN: Botulinum toxin for achalasia. Lancet 1999, 341:244\u2013245.","journal-title":"Lancet"},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM199907083410201","volume":"341","author":"G Brisinda","year":"1999","unstructured":"Brisinda G, Maria G, Bentivoglio AR, et al.: A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Eng J Med 1999, 341:65\u201369.","journal-title":"N Eng J Med"},{"key":"47_CR7","unstructured":"Knusel B, Grant M, Loesser JD: Intramuscular injection of botulinum toxin type A in chronic low back pain associated with muscle spasm. Poster presented at the American Pain Society Meeting; San Diego, CA. November 1998;"},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/WNL.40.2.277","volume":"40","author":"J Jankovic","year":"1990","unstructured":"Jankovic J, Schwartz K: Botulinum toxin injections for cervical dystonia. Neurology 1990, 40:277\u2013280.","journal-title":"Neurology"},{"key":"47_CR9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1468-1331.1997.tb00292.x","volume":"4","author":"M Relja","year":"1997","unstructured":"Relja M: Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol 1997, 4(suppl):S1-S73.","journal-title":"Eur J Neurol"},{"key":"47_CR10","unstructured":"Anand K, Singh MM, Prasad A: Botulinum toxin type A in prophylactic treatment of migraine. Poster presented at the 17th World Congress of Neurology; London, UK. June 17\u201322, 2001;"},{"key":"47_CR11","first-page":"499","volume":"21","author":"L Robbins","year":"2001","unstructured":"Robbins L: Botulinum toxin for cluster headache: 6 cases [abstract]. Cephalalgia 2001, 21:499.","journal-title":"Cephalalgia"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/033310240102100707","volume":"21","author":"H Gobel","year":"2001","unstructured":"Gobel H, Heinze A, Heinze K: Botulinum toxin A in the treatment of chronic paroxysmal hemicrania-a case report [abstract]. Cephalalgia 2001, 21:506.","journal-title":"Cephalalgia"},{"key":"47_CR13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/033310240102100707","volume":"21","author":"H Gobel","year":"2001","unstructured":"Gobel H, Heinze A, Heinze K: Botulinum toxin A is effective is cases of oromandibular dysfunction even if previous bite splint therapy has proved unsuccessful. Cephalalgia 2001, 21:514.","journal-title":"Cephalalgia"},{"key":"47_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-85173-5_1","volume":"195","author":"C Montecucco","year":"1995","unstructured":"Montecucco C: Clostridial neurotoxins: the molecular pathogenesis of tetanus and botulism. Curr Top Microbiol Immunol 1995, 195:1\u2013278.","journal-title":"Curr Top Microbiol Immunol"},{"key":"47_CR15","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/WNL.41.11.1800","volume":"41","author":"K Alderson","year":"1991","unstructured":"Alderson K, Holds JB, Anderson RL: Botulinuminduced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 1991, 41:1800\u20131805.","journal-title":"Neurology"},{"key":"47_CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/sder.2001.25964","volume":"20","author":"AW Klein","year":"2001","unstructured":"Klein AW: Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg 2001, 20:109\u2013120.","journal-title":"Semin Cutan Med Surg"},{"key":"47_CR17","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","volume":"96","author":"A Pavia de","year":"1999","unstructured":"de Pavia A, Meunier FA, Molgo J, et al.: Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci 1999, 96:3200\u20133205. A good article.","journal-title":"Proc Natl Acad Sci"},{"key":"47_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004150170261","volume":"248","author":"KR Aoki","year":"2001","unstructured":"Aoki KR: Pharmacology and immunology of botulinum toxin serotypes. J Neurol 2001, 248(suppl):1\u201310. An important paper.","journal-title":"J Neurol"},{"key":"47_CR19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1526-4610.2001.01193.x","volume":"41","author":"JD Rollnik","year":"2001","unstructured":"Rollnik JD, Karst M, Fink K, Dengler R: Botulinum toxin type A and EMG: a key to the understand of chronic tension-type headaches? Headache 2001, 41:985\u2013989. Outstanding review.","journal-title":"Headache"},{"key":"47_CR20","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1526-4610.1994.hed3408458.x","volume":"34","author":"JA Zwart","year":"1994","unstructured":"Zwart JA, Bovim G, Sand T, Sjaastad O: Tension headache: botulinum toxin paralysis of temporal muscles. Headache 1994, 34:458\u2013462.","journal-title":"Headache"},{"key":"47_CR21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","volume":"38","author":"MJ Welch","year":"2000","unstructured":"Welch MJ, Punkiss JR, Foster KA: Sensitivity of embryonic rat dorsal root ganglia neurons to clostridium botulinum neurotoxins. Toxincon 2000, 38:245\u2013258.","journal-title":"Toxincon"},{"key":"47_CR22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1152\/jn.1999.81.2.479","volume":"81","author":"H Yamamura","year":"1999","unstructured":"Yamamura H, Malick A, Chamberlin NL, Burnstein R: Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 1999, 81:479\u2013493.","journal-title":"J Neurophysiol"},{"key":"47_CR23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1526-4610.1997.3708486.x","volume":"37","author":"BM Fusco","year":"1997","unstructured":"Fusco BM, Colantoni O, Giavovazzo M: Alteration of central excitation circuits in chronic headache and analgesic misuse. Headache 1997, 37:486\u2013491.","journal-title":"Headache"},{"key":"47_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1526-4610.2000.00066.x","volume":"40","author":"S Silberstein","year":"2000","unstructured":"Silberstein S, Mathew NT, Saper J: Botulinum toxin type A as a migraine preventive treatment. Headache 2000, 40:445\u2013450.","journal-title":"Headache"},{"key":"47_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1468-2982.2000.020004421.x","volume":"20","author":"MF Brin","year":"2000","unstructured":"Brin MF, Swope DM, O\u2019brien C, et al.: Botox for migraine: double-blind, placebo-controlled, regionspecific evaluation. Cephalalgia 2000, 20:421\u2013422.","journal-title":"Cephalalgia"},{"key":"47_CR26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","volume":"123","author":"WJ Binder","year":"2000","unstructured":"Binder WJ, Brin MF, Blitzer A, et al.: Botulinum toxin type A for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 2000, 123:669\u2013676.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"47_CR27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/sder.2001.24423","volume":"20","author":"WJ Binder","year":"2001","unstructured":"Binder WJ, Brin MF, Blitzer A, Pogoda JM: Botulinum toxin type A for treatment of migraine. Semin Cutan Med Surg 2001, 20:93\u2013100.","journal-title":"Semin Cutan Med Surg"},{"key":"47_CR28","first-page":"422","volume":"20","author":"A Mauskop","year":"2000","unstructured":"Mauskop A, Basdeo R: Botulinum toxin A is effective prophylactic therapy for migraines. Cephalalgia 2000, 20:422.","journal-title":"Cephalalgia"},{"key":"47_CR29","unstructured":"Tatarian GT: Effect of botulinum toxin type A on patients with menstrual migraine headache: a retrospective chart view. Presented at Diamond Practicing Physician\u2019s Approach to the Difficult Headache Patient; Lake Buena Vista, FL. July 17\u201321, 2001;"},{"key":"47_CR30","unstructured":"Parcells PR: A retrospective chart review of repeated doses of botulinum toxin type A for the treatment of migraine headache. Presented at Diamond Practicing Physician\u2019s Approach to the Difficult Headache Patient; Lake Buena Vista, FL. July 17\u201321, 2001;"},{"key":"47_CR31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1468-2982.2000.020004332.x","volume":"20","author":"JA Smuts","year":"2000","unstructured":"Smuts JA, Barnard PWA: Botulinum toxin type A in the treatment of headache syndromes: a clinical report of 79 patients. Cephalalgia 2000, 20:332.","journal-title":"Cephalalgia"},{"key":"47_CR32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1526-4610.2001.041007658.x","volume":"41","author":"WJ Schmitt","year":"2001","unstructured":"Schmitt WJ, Slowey E, Fravi N, et al.: Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache 2001, 41:658\u2013664. A good article.","journal-title":"Headache"},{"key":"47_CR33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4610.2000.00044.x","volume":"40","author":"JD Rolnik","year":"2000","unstructured":"Rolnik JD, Tannenberger O, Schubert M, et al.: Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache 2000, 40:300\u2013305. An excellent paper.","journal-title":"Headache"},{"key":"47_CR34","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1111\/j.1468-1331.1999.tb00044.x","volume":"6","author":"JA Smuts","year":"1999","unstructured":"Smuts JA, Baker MK, Smuts HM, et al.: Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999, 6(suppl):S99-S102. A good article.","journal-title":"Eur J Neurol"},{"key":"47_CR35","first-page":"A349","volume":"56","author":"MA Relja","year":"2001","unstructured":"Relja MA, Klepac N: Botulinum toxin type A as a prophylactic treatment in chronic tension-type headache: long-term follow-up study. Neurology 2001, 56(suppl):A349-A350.","journal-title":"Neurology"},{"key":"47_CR36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1526-4610.2000.00033.x","volume":"40","author":"BJ Freund","year":"2000","unstructured":"Freund BJ, Schwartz M: Treatment of chronic cervicalassociated headache with botulinum toxin A: a pilot study. Headache 2000, 40:231\u2013236.","journal-title":"Headache"},{"key":"47_CR37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/PL00007818","volume":"248","author":"H Gobel","year":"2001","unstructured":"Gobel H, Heinze A, Heinze-Kuhn K, Jost WH: Evidencebased medicine: botulinum toxin A in migraine and tension-type headache. J Neurol 2001, 248(suppl):34\u201338.","journal-title":"J Neurol"},{"key":"47_CR38","unstructured":"Blumenfeld A: Decreases in medication use and cost after botulinum toxin type A treatment for intractable chronic headache: case studies. Presented at Diamond Practicing Physician\u2019s Approach to the Difficult Headache Patient; Lake Buena Vista, FL. July 17\u201321, 2001;"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-002-0047-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-002-0047-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-002-0047-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:46Z","timestamp":1559437006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-002-0047-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s11940-002-0047-8","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}